Overseas Expansion And InsurTech Collaborations Will Unlock Future Diversification

Published
23 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
₩3,337.50
6.4% undervalued intrinsic discount
14 Aug
₩3,125.00
Loading
1Y
10.8%
7D
-8.8%

Author's Valuation

₩3.3k

6.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update01 May 25
Fair value Increased 5.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Key Takeaways

  • Overseas expansion and digital innovation are diversifying revenue streams, reducing costs, and supporting margin expansion.
  • Strong local demand for retirement and health products is driving higher-margin sales and stabilizing future earnings.
  • Earnings face pressure from increased claims and regulatory demands, amplified by market competition, interest rate sensitivity, and demographic-driven stagnation in the domestic insurance market.

Catalysts

About Hanwha Life Insurance
    Provides insurance products to individual and corporate customers in South Korea and internationally.
What are the underlying business or industry changes driving this perspective?
  • Ongoing overseas expansion, including acquisitions in the U.S. (Velocity Clearing) and investments in Southeast Asian banking, positions Hanwha Life to benefit from increasing global demand for wealth management and protection solutions, supporting long-term premium growth and diversification of revenue streams.
  • The growing demand for retirement and health products, fueled by South Korea's aging demographic, is driving increased sales of whole life and health insurance policies, which have higher margins and improve long-term revenue and underwriting profitability.
  • Significant digital capability enhancements-through direct-to-consumer platforms, expanded InsurTech partnerships, and integration of new digital assets-are reducing distribution and administrative costs over time, expected to support margin expansion.
  • Persistent improvement in policy persistency rates (13th and 25th month ratios) and the sale of higher-margin, medium and long-term premium products are stabilizing the in-force CSM and dampening balance sheet volatility, supporting more predictable future earnings.
  • Active asset management-shifting toward high-quality, long-dated bonds and alternative assets-is expected to improve investment income stability and mitigate margin pressure from low interest rates, supporting overall net earnings growth.

Hanwha Life Insurance Earnings and Revenue Growth

Hanwha Life Insurance Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Hanwha Life Insurance's revenue will decrease by 58.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 2.9% today to 49.7% in 3 years time.
  • Analysts expect earnings to reach ₩790.3 billion (and earnings per share of ₩934.93) by about August 2028, up from ₩638.3 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 3.7x on those 2028 earnings, down from 3.9x today. This future PE is lower than the current PE for the KR Insurance industry at 6.9x.
  • Analysts expect the number of shares outstanding to decline by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 12.76%, as per the Simply Wall St company report.

Hanwha Life Insurance Future Earnings Per Share Growth

Hanwha Life Insurance Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Hanwha Life Insurance's profitability and net income are vulnerable to rising claims payouts and higher costs associated with onerous contracts-particularly health-related riders and living benefits-which have already led to reduced insurance income and may continue to pressure earnings if not controlled.
  • The company's earnings are highly sensitive to changes in interest rates; further declines in interest rates could significantly impact asset valuations, increase liabilities, lower the K-ICS solvency ratio, and compress net investment margins, creating ongoing earnings and capital volatility.
  • Stricter regulatory capital requirements-such as additional surrender reserve requirements and potential changes to liability discount rate and duration gap regulations-could constrain Hanwha Life's ability to distribute dividends, limit investment flexibility, and erode shareholder returns despite improved underlying profit.
  • Intensifying market competition and premium cuts-especially in health insurance-are incentivizing policyholders to churn (cancel and repurchase new policies), which increases surrender rates, undermines persistency, and potentially destabilizes in-force CSM balances, negatively impacting revenue and CSM growth.
  • Slowing growth prospects in the domestic Korean insurance market due to demographic headwinds (aging and shrinking population) and gradual digital disruption from non-traditional players present long-term risks of stagnating premium income and market share, challenging Hanwha Life's ability to sustain long-term revenue and earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of ₩3337.5 for Hanwha Life Insurance based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₩4500.0, and the most bearish reporting a price target of just ₩1900.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ₩1589.0 billion, earnings will come to ₩790.3 billion, and it would be trading on a PE ratio of 3.7x, assuming you use a discount rate of 12.8%.
  • Given the current share price of ₩3335.0, the analyst price target of ₩3337.5 is 0.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives